Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT…
Conditions studied
Primary Open Angle Glaucoma (POAG)
About this study
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
Interventions
- Device: Direct Selective Laser Trabeculoplasty — DSLT using the Belkin Vision Eagle Device
Primary outcomes
- IOP reduction at 6 months washed out post-DSLT compared with washed out baseline IOP. (6 Months post-DSLT)
Eligibility information
Study locations
- Select Eye Care, Elkridge, Maryland 21075 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.